Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Aplan

Blood

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Blood|March 5, 2005
"You break it, you fix it."Peter D Aplan
Blood|June 9, 2016
Therapeutic targeting of IL-7Rα signaling pathways in ALL treatmentSarah D Cramer, Peter D Aplan, Scott K Durum
Blood|September 28, 2011
NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insightsSheryl M Gough, Christopher I Slape, Peter D Aplan
Blood|April 22, 2004
NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutationRhonna M Gurevich, Peter D Aplan, R Keith Humphries
Blood|June 21, 2008
Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and CblChristopher Slape, Leah Y Liu, Sarah Beachy, et al.
Blood|March 10, 2005
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemiaYing-Wei Lin, Christopher Slape, Zhenhua Zhang, et al.
Blood|November 12, 2005
Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphomaYing-Wei Lin, Rebecca A Nichols, John J Letterio, et al.
Blood|July 10, 2013
Genetic interaction between Kit and SclJulie Lacombe, Gorazd Krosl, Mathieu Tremblay, et al.
Blood|December 17, 2009
Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic miceDavid Caudell, David P Harper, Rachel L Novak, et al.
Blood|August 29, 2012
Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse modelHaiming Xu, Silvia Menendez, Brigitte Schlegelberger, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Blood|March 5, 2005
"You break it, you fix it."Peter D Aplan
Blood|June 9, 2016
Therapeutic targeting of IL-7Rα signaling pathways in ALL treatmentSarah D Cramer, Peter D Aplan, Scott K Durum
Blood|September 28, 2011
NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insightsSheryl M Gough, Christopher I Slape, Peter D Aplan
Blood|April 22, 2004
NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutationRhonna M Gurevich, Peter D Aplan, R Keith Humphries
Blood|June 21, 2008
Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and CblChristopher Slape, Leah Y Liu, Sarah Beachy, et al.
Blood|March 10, 2005
NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemiaYing-Wei Lin, Christopher Slape, Zhenhua Zhang, et al.
Blood|November 12, 2005
Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphomaYing-Wei Lin, Rebecca A Nichols, John J Letterio, et al.
Blood|July 10, 2013
Genetic interaction between Kit and SclJulie Lacombe, Gorazd Krosl, Mathieu Tremblay, et al.
Blood|December 17, 2009
Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic miceDavid Caudell, David P Harper, Rachel L Novak, et al.
Blood|August 29, 2012
Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse modelHaiming Xu, Silvia Menendez, Brigitte Schlegelberger, et al.
Pageof 2